Literature DB >> 24058387

Relationship between Uric Acid Levels and Diagnostic and Prognostic Outcomes in Acute Heart Failure.

Queen Henry-Okafor1, Sean P Collins, Cathy A Jenkins, Karen F Miller, David J Maron, Allen J Naftilan, Neal Weintraub, Gregory J Fermann, John McPherson, Santosh Menon, Douglas B Sawyer, Alan B Storrow.   

Abstract

OBJECTIVES: We evaluated the association of plasma uric acid alone and in combination with b-type natriuretic peptide (BNP) for emergency department (ED) diagnosis and 30-day prognosis in patients evaluated for acute heart failure (AHF).
METHODS: We prospectively enrolled 322 adult ED patients with suspected AHF. Wilcoxon rank sum test, multivariable logistic regression and likelihood ratio (LR) tests were used for statistical analyses.
RESULTS: Uric acid's diagnostic utility was poor and failed to show significant associations with 30-day clinical outcomes. Uric acid also did not add significantly to BNP results.
CONCLUSION: Among ED patients with suspected AHF, uric acid has poor diagnostic and prognostic utility.

Entities:  

Keywords:  Acute heart failure; b-type natriuretic peptide; prognostic outcomes; uric acid

Year:  2012        PMID: 24058387      PMCID: PMC3777695          DOI: 10.2174/1875318301205010009

Source DB:  PubMed          Journal:  Open Biomark J


  26 in total

1.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Jane Marsh; Lesley A Stevens; John W Kusek; Frederick Van Lente
Journal:  Clin Chem       Date:  2007-03-01       Impact factor: 8.327

2.  Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings.

Authors:  Gary S Mak; Anthony DeMaria; Paul Clopton; Alan S Maisel
Journal:  Am Heart J       Date:  2004-11       Impact factor: 4.749

3.  Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure.

Authors:  Jennifer B Neily; Kathleen H Toto; Elizabeth B Gardner; J Eduardo Rame; Clyde W Yancy; Michael A Sheffield; Daniel L Dries; Mark H Drazner
Journal:  Am Heart J       Date:  2002-01       Impact factor: 4.749

4.  Gout, allopurinol use, and heart failure outcomes.

Authors:  George Thanassoulis; James M Brophy; Hugues Richard; Louise Pilote
Journal:  Arch Intern Med       Date:  2010-08-09

5.  Hyperuricemia in acute heart failure. More than a simple spectator?

Authors:  Anna L Alimonda; Julio Núñez; Eduardo Núñez; Oliver Husser; Juan Sanchis; Vicent Bodí; Gema Miñana; Rocio Robles; Luis Mainar; Pilar Merlos; Helene Darmofal; Angel Llácer
Journal:  Eur J Intern Med       Date:  2008-06-10       Impact factor: 4.487

6.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

Authors:  M Senni; C M Tribouilloy; R J Rodeheffer; S J Jacobsen; J M Evans; K R Bailey; M M Redfield
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

7.  Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study.

Authors:  Alan S Maisel; Paul Clopton; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Gabriel Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Vikas Bhalla; Howard C Herrmann; Marie Claude Aumont; Peter A McCullough
Journal:  Am Heart J       Date:  2004-06       Impact factor: 4.749

Review 8.  Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure.

Authors:  Corinna Bergamini; Mariantonietta Cicoira; Andrea Rossi; Corrado Vassanelli
Journal:  Eur J Heart Fail       Date:  2009-04-04       Impact factor: 15.534

9.  Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

Authors:  Alan Maisel; Judd E Hollander; David Guss; Peter McCullough; Richard Nowak; Gary Green; Mitchell Saltzberg; Stefanie R Ellison; Meenakshi Awasthi Bhalla; Vikas Bhalla; Paul Clopton; Robert Jesse
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

Review 10.  Uric acid and oxidative stress: relative impact on cardiovascular risk?

Authors:  Pasquale Strazzullo; Juan Garcia Puig
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-07       Impact factor: 4.222

View more
  2 in total

1.  High Serum Uric Acid is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases.

Authors:  Yoshitsugu Oki; Makoto Kawai; Kosuke Minai; Kazuo Ogawa; Yasunori Inoue; Satoshi Morimoto; Toshikazu Tanaka; Tomohisa Nagoshi; Takayuki Ogawa; Michihiro Yoshimura
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 2.  Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review.

Authors:  Marko Kumrić; Josip A Borovac; Tina Tičinović Kurir; Joško Božić
Journal:  Life (Basel)       Date:  2021-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.